Search Results - Chinnathambi, A.

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Potential protective effects of ursolic acid against gamma irradiation-induced damage are mediated through the modulation of diverse inflammatory mediators

    Potential protective effects of ursolic acid against gamma irradiation-induced damage are mediated through the modulation of diverse inflammatory mediators by Wang, H., Sim, M., Loke, W., Chinnathambi, A., Alharbi, S., Tang, F., Sethi, Gautam

    Published 2017
    Get full text
  2. 2
    Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy

    Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy by Dai, X., Zhang, J., Arfuso, Frank, Chinnathambi, A., Zayed, M., Alharbi, S., Kumar, A., Ahn, K., Sethi, G.

    Published 2015
    Get full text
  3. 3
    NF-κB in cancer therapy

    NF-κB in cancer therapy by Li, F., Zhang, J., Arfuso, Frank, Chinnathambi, A., Zayed, M., Alharbi, S., Kumar, Alan Prem, Ahn, K., Sethi, G.

    Published 2015
    Get full text
  4. 4
    Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent

    Viperatoxin-II: A novel viper venom protein as an effective bactericidal agent by Samy, R., Stiles, B., Chinnathambi, A., Zayed, M., Alharbi, S., Franco, O., Rowan, E., Kumar, A., Lim, L., Sethi, Gautam

    Published 2015
    Get full text
  5. 5
    The multifaceted role of curcumin in cancer prevention and treatment

    The multifaceted role of curcumin in cancer prevention and treatment by Shanmugam, M., Rane, G., Kanchi, M., Arfuso, Frank, Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., Sethi, G.

    Published 2015
    Get full text
  6. 6
    Oleuropein induces apoptosis via abrogating NF-?B activation cascade in estrogen receptor–negative breast cancer cells

    Oleuropein induces apoptosis via abrogating NF-?B activation cascade in estrogen receptor–negative breast cancer cells by Liu, L., Ahn, K., Shanmugam, M., Wang, H., Shen, H., Arfuso, Frank, Chinnathambi, A., Alharbi, S., Chang, Y., Sethi, G., Tang, F.

    Published 2018
    Get full text
  7. 7
    Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells

    Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells by Mohan, C., Anilkumar, N., Rangappa, S., Shanmugam, M., Mishra, S., Chinnathambi, A., Alharbi, S., Bhattacharjee, A., Sethi, G., Kumar, Alan Prem, Basappa, Rangappa, K.

    Published 2018
    Get full text
  8. 8
    Role of novel histone modifications in cancer

    Role of novel histone modifications in cancer by Shanmugam, M., Arfuso, Frank, Arumugam, S., Chinnathambi, A., Jinsong, B., Warrier, Sudha, Wang, L., Kumar, A., Ahn, K., Sethi, G., Lakshmanan, M.

    Published 2018
    Get full text
  9. 9
    Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer

    Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer by Zhang, J., Sikka, S., Siveen, K., Lee, J., Um, J., Kumar, Alan Prem, Chinnathambi, A., Alharbi, S., Basappa, Rangappa, K., Sethi, G., Ahn, K.

    Published 2017
    Get full text
  10. 10
    Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356

    Correction: Role of novel histone modifications in cancer [Oncotarget, 9, (2018), (11414-11426)] doi 10.18632/oncotarget.23356 by Shanmugam, M., Arfuso, Frank, Arumugam, S., Chinnathambi, A., Bian, J., Warrier, Sudha, Wang, L., Kumar, Alan Prem, Ahn, K., Sethi, G., Lakshmanan, M.

    Published 2018
    Get full text
  11. 11
    Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics

    Novel phospholipase A2 inhibitors from python serum are potent peptide antibiotics by Samy, R., Thwin, M., Stiles, B., Satyanarayana-Jois, S., Chinnathambi, A., Zayed, M., Alharbi, S., Siveen, K., Sikka, S., Kumar, Alan Prem, Sethi, G., Lim, L.

    Published 2015
    Get full text
  12. 12
    Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer

    Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-?B signaling cascade in gastric cancer by Manu, K., Shanmugam, M., Ramachandran, L., Li, F., Siveen, K., Chinnathambi, A., Zayed, M., Alharbi, S., Arfuso, Frank, Kumar, A., Ahn, K., Sethi, G.

    Published 2015
    Get full text
  13. 13
    Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

    Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (201... by Manu, K., Shanmugam, M., Ramachandran, L., Li, F., Siveen, K., Chinnathambi, A., Zayed, M., Alharbi, S., Arfuso, Frank, Kumar, Alan Prem, Ahn, K., Sethi, G.

    Published 2018
    Get full text
  14. 14
    Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1

    Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1 by Wang, L., Chan, C., Wong, A., Wong, F., Lim, S., Chinnathambi, A., Alharbi, S., Lee, L., Soo, R., Yong, W., Lee, S., Ho, P., Sethi, Gautam, Goh, B.

    Published 2017
    Get full text
  15. 15
    NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance

    NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance by Monisha, J., Roy, N., Padmavathi, G., Banik, K., Bordoloi, D., Khwairakpam, A., Arfuso, Frank, Chinnathambi, A., Alahmadi, T., Alharbi, S., Sethi, G., Kumar, Alan Prem, Kunnumakkara, A.

    Published 2018
    Get full text
  16. 16
    Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

    Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis by Shanmugam, M., Ahn, K., Hsu, A., Woo, C., Yuan, Y., Tan, K., Chinnathambi, A., Alahmadi, T., Alharbi, S., Koh, A., Arfuso, Frank, Huang, R., Lim, L., Alan, G., Kumar, A.

    Published 2018
    Get full text
  17. 17
    N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-kB signaling pathway

    N-substituted pyrido-1,4-Oxazin-3-ones induce apoptosis of hepatocellular carcinoma cells by targeting NF-kB signaling pathway by Mohan, C., Bharathkumar, H., Dukanya, Rangappa, S., Shanmugam, M., Chinnathambi, A., Alharbi, S., Alahmadi, T., Bhattacharjee, A., Lobie, P., Deivasigamani, A., Hui, K., Sethi, G., Basappa, Rangappa, K., Kumar, Alan Prem

    Published 2018
    Get full text
  18. 18
    Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model

    Inhibition of p300 Lysine Acetyltransferase activity by Luteolin reduces tumor growth in head and neck squamous cell carcinoma (HNSCC) xenograft mouse model by Selvi, R., Swaminathan, A., Chatterjee, S., Shanmugam, M., Li, F., Ramakrishnan, G., Siveen, K., Chinnathambi, A., Emam, Z., Alharbi, S., Basha, J., Bhat, A., Vasudevan, M., Dharmarajan, Arunasalam, Sethi, G., Kundu, T.

    Published 2015
    Get full text
  19. 19
    A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma

    A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma by Dai, X., Wang, L., Deivasigamni, A., Looi, C., Karthikeyan, C., Trivedi, P., Chinnathambi, A., Alharbi, S., Arfuso, Frank, Dharmarajan, Arunasalam, Goh, B., Hui, K., Kumar, Alan Prem, Mustafa, M., Sethi, Gautam

    Published 2017
    Get full text

Search Tools: